ECCLESFIELD GROUP PRACT — All Prescriptions & Medications — Page 7
Practice Code: C88039 | SHEFFIELD, S35 9XQ
Showing results 301-350 of 632
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Colesevelam hydrochloride | 83 | 15.1K | £5.8K | +118.7% ▲ |
| Other individually formulated bought in preparations | 83 | 1,556 | £446 | +154.0% ▲ |
| 83 | 7,980 | £2.2K | -2.5% ▼ | |
| 83 | 30.4K | £2.0K | +117.7% ▲ | |
| Temazepam | 82 | 2,730 | £2.4K | +43.3% ▲ |
| Menthol | 82 | 25.9K | £936 | +191.2% ▲ |
| Oxcarbazepine | 80 | 4,228 | £1.3K | +186.1% ▲ |
| Vitamins caps | 79 | 1,099 | £27 | +43.8% ▲ |
| Permethrin | 79 | 5,128 | £1.4K | +109.7% ▲ |
| Formoterol/glycopyrronium/budesonide | 78 | 78 | £3.3K | +29.5% ▲ |
| Dorzolamide | 78 | 2,505 | £1.1K | -6.1% ▼ |
| Medroxyprogesterone acetate | 77 | 5,915 | £1.3K | +101.2% ▲ |
| Vortioxetine | 75 | 1,204 | £1.1K | +8.1% ▲ |
| Midodrine hydrochloride | 74 | 8,618 | £1.6K | +51.9% ▲ |
| Fenofibrate | 74 | 2,072 | £232 | -23.5% ▼ |
| Methenamine hippurate | 74 | 2,796 | £747 | -18.6% ▼ |
| Mometasone furoate/olopatadine hydrochloride | 73 | 79 | £1.0K | +572.0% ▲ |
| Cinnarizine | 72 | 8,096 | £366 | +53.9% ▲ |
| Acamprosate calcium | 72 | 3,024 | £342 | +106.7% ▲ |
| Anastrozole | 72 | 2,296 | £87 | -20.9% ▼ |
| Bicalutamide | 72 | 756 | £45 | +122.6% ▲ |
| 72 | 4,098 | £509 | +45.7% ▲ | |
| 71 | 1,370 | £826 | -8.2% ▼ | |
| Co-dydramol (Dihydrocodeine/paracetamol) | 70 | 11.5K | £505 | -61.0% ▼ |
| Tacrolimus | 70 | 2,610 | £2.0K | +29.8% ▲ |
| Adapalene and benzoyl peroxide | 70 | 3,435 | £1.5K | +31.1% ▲ |
| 70 | 700 | £1.9K | +46.4% ▲ | |
| Flecainide acetate | 69 | 3,992 | £156 | -11.6% ▼ |
| Clonidine hydrochloride | 69 | 3,139 | £321 | +29.3% ▲ |
| Febuxostat | 69 | 1,918 | £171 | +84.7% ▲ |
| Heparinoid | 69 | 8,750 | £479 | +163.1% ▲ |
| Metronidazole | 69 | 2,715 | £673 | +83.6% ▲ |
| Phenobarbital | 67 | 2,800 | £529 | +117.9% ▲ |
| Neomycin sulfate | 67 | 1,095 | £139 | +13.0% ▲ |
| Benzoyl peroxide and clindamycin phosphate | 67 | 3,300 | £1.4K | -0.1% vs avg |
| Lofepramine hydrochloride | 66 | 4,480 | £1.9K | +120.6% ▲ |
| Rifaximin | 66 | 1,162 | £5.4K | +145.8% ▲ |
| Nortriptyline | 65 | 3,576 | £181 | -55.3% ▼ |
| Ondansetron hydrochloride | 65 | 3,865 | £2.0K | +34.0% ▲ |
| Calcium carbonate | 65 | 5,513 | £479 | -1.2% vs avg |
| Brinzolamide/brimonidine | 65 | 475 | £834 | +89.5% ▲ |
| Tibolone | 64 | 1,323 | £124 | +109.1% ▲ |
| Celecoxib | 64 | 3,700 | £361 | -3.1% ▼ |
| Metoclopramide hydrochloride | 63 | 6,355 | £482 | -24.0% ▼ |
| Fentanyl | 63 | 630 | £1.4K | -38.5% ▼ |
| Leuprorelin acetate | 63 | 63 | £14.2K | +35.9% ▲ |
| Methylprednisolone acetate | 63 | 64 | £244 | -45.4% ▼ |
| Glucose | 61 | 6,095 | £551 | +17.3% ▲ |
| Norethisterone | 61 | 3,641 | £599 | +25.8% ▲ |
| Brinzolamide | 61 | 335 | £311 | -53.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.